Ng D-L, Tie S-W, Ong P-C, Lim W-S, Tengku-Muhammad T-S, Choo Q-C, Chew C-H. Rapamycin pre-treatment abrogates Tumour Necrosis Factor-α down-regulatory effects on LXR-α and PXR mRNA expression via inhibition of c-Jun N-terminal kinase 1 activation in HepG2 cells. Electron. J. Biotechnol. [Internet]. 2011 May 13 [cited 2024 Nov. 23];14(3). Available from: https://www.ejbiotechnology.info/index.php/ejbiotechnology/article/view/v14n3-9